Search Results - Sumati Gupta
- Showing 1 - 12 results of 12
-
1
Response to: Comment on “Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator... by Sumati Gupta, Umang Swami, Gliceida M Galarza Fortuna
Published in Journal for ImmunoTherapy of Cancer (2025-05-01)Get full text
Article -
2
-
3
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the s... by Matthew Gumbleton, Stephanie Allan, Hannah Conway, Kenneth Boucher, James Marvin, Josiah Hawks, William Burnett, Matthew Van Brocklin, Jonathan Whisenant, Glynn Gilcrease, Sumati Gupta
Published in BMC Research Notes (2023-02-01)Get full text
Article -
4
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers by Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, Blake Nordblad, Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami
Published in Heliyon (2022-09-01)Get full text
Article -
5
Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab by Georges Gebrael, Yeonjung Jo, Zeynep Irem Ozay, Varun Nandakumar, Antonio Cigliola, Valentina Tateo, Edwin Lin, Micah Ostrowski, Nicolas Sayegh, Ethan Murdock, Vinay Mathew Thomas, Sumati Gupta, Neeraj Agarwal, Umang Swami
Published in Bladder Cancer (2026-01-01)Get full text
Article -
6
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial by Adriana M Coletta, Lea Haverbeck Simon, Kelsey Maslana, Sarah Taylor, Kish Larson, Pamela A Hansen, Vinay Mathew Thomas, Cornelia M Ulrich, Manish Kohli, Jonathan Chipman, Umang Swami, Sumati Gupta, Benjamin L Maughan, Neeraj Agarwal
Published in BMC Cancer (2024-04-01)Get full text
Article -
7
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and met... by Kevin Conlon, Robert Wesolowski, Douglas G McNeel, John A Thompson, Rom Leidner, Andrea Wang-Gillam, Sumati Gupta, Nancy Lewis, George N Pavlakis, Lang Ho Lee, Monica Chaudhari, Nadia Hassounah, Jong Bong Lee, Jessica A O’Keeffe
Published in Journal for ImmunoTherapy of Cancer (2023-10-01)Get full text
Article -
8
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery by Kavita Dhodapkar, Brent A Hanks, Holden T Maecker, Siwen Hu-Lieskovan, Sumati Gupta, Yoshinobu Koguchi, Srabani Bhaumik, Cristina Maccalli, Sylvia Janetzki, Yingdong Zhao, Jean-Charles J B Grivel, Thomas O Kleen, Amanda W Lund, Yolanda D Mahnke, Ruslan D Novosiadly, Senthamil R Selvan, Tasha Sims
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
9
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT) by Neeraj Agarwal, Sumati Gupta, Roger Li, Rohit K Jain, Daniel Grass, Michael Poch, Umang Swami, Alejandro Sanchez, Gliceida M. Galarza Fortuna, Benjamin L Maughan, Christopher Dechet, Julia Beck, Ekke Schuetz, Brock O’Neil, Shane Lloyd, Jonathan Tward, Tenzin Phunrab, Josiah Lyn Hawks, Kenneth M Boucher
Published in Journal for ImmunoTherapy of Cancer (2025-03-01)Get full text
Article -
10
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors by Kevin Conlon, Douglas G McNeel, John A Thompson, Sema Kurtulus, Rom Leidner, Thomas A Waldmann, Andrea Wang-Gillam, William D Figg, Sumati Gupta, Cristina Bergamaschi, George N Pavlakis, Antonio Valentin, Barbara K Felber, Mario Roederer, Dionysios C Watson, Cody J Peer, E Lake Potter, Nehal S Parikh, Debby Long, Lang Ho Lee, Niladri Roy Chowdhury, Florent Bender
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Get full text
Article -
11
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in pat... by Christy Ralph, Sumati Gupta, Matthew Zibelman, Brendan D Curti, Kevin J Harrington, Steven J O'Day, Andrew G Hill, David C Campbell, Gavin M Wright, David E Gerber, Jonathan E Rosenberg, Jaime R Merchan, Charles M Rudin, Hardev S Pandha, Wallace L Akerley, Daphne Day, Timothy D Clay, Ross R Jennens, Yixin Ren, Emmett V Schmidt, Lisa Guttman
Published in Journal for ImmunoTherapy of Cancer (2023-01-01)Get full text
Article -
12
Germline whole-exome sequencing reveals FOXP3-related gene variants conferring urinary cancer susceptibility and associated with immune escape by Laura Graham, Kamal Kant Sahu, Rohit Jain, Sumati Gupta, Yousef Zakharia, Jad Chahoud, Bodour Salhia, Kenneth Nepple, Christopher A Moskaluk, Bing-Jian Feng, Stephen Edge, Eric A Singer, Michelle Churchman, Alejandro Sanchez, Kenneth M Boucher, Lindsey Byrne, Wendy Kohlmann, David A Nix, Aaron Atkinson, Courtney Carroll, Chris J Stubben, Jill Kolesar, Gregory Riedlinger, Bryan P Schneider, Ahmad Shabsigh, Bradley R Cairns
Published in Journal for ImmunoTherapy of Cancer (2025-09-01)Get full text
Article